galactosyl-(1-3)galactose has been researched along with ST Elevation Myocardial Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumgart, KW; Bhindi, R; Celermajer, DS; Figtree, GA; Finemore, M; Grieve, SM; Hansen, PS; Hansen, T; Kott, KA; Nicholls, SJ; van Nunen, SA; Vernon, ST; Ward, MR; Yang, J | 1 |
1 other study(ies) available for galactosyl-(1-3)galactose and ST Elevation Myocardial Infarction
| Article | Year |
|---|---|
Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-α-1,3 (α-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment-Elevated Myocardial Infarction.
Topics: Aged; Animals; Cohort Studies; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Disaccharides; Female; Food Hypersensitivity; Humans; Immunoglobulin E; Male; Middle Aged; Plaque, Atherosclerotic; Prospective Studies; Risk Factors; Severity of Illness Index; ST Elevation Myocardial Infarction; Vascular Calcification | 2022 |